Japanese encephalitis (JE) survivors often present with nigrostriatal aftereffects with parkinsonian features. A 67-year-old woman with JE showed right-dominant clinical parkinsonism and left-dominant substantia nigra lesions after magnetic resonance imaging (MRI). Dopamine transporter (DAT) imaging using 
Introduction
Japanese encephalitis (JE) is the most serious infectious disease of the central nervous system. Approximately 15% of JE patients die during the acute phase of the illness, and most survivors present with neurological aftereffects, including striatal dysfunctions and parkinsonian features (1) . Presynaptic striatal dysfunctions recently became detectable by dopamine transporter (DAT) imaging, which is usually applied to neurodegenerative disorders such as Parkinson's disease and progressive supranuclear palsy (PSP). However, there are only limited reports of DAT imaging for JE patients (2, 3) . In this paper, we report a JE patient that presented with parkinsonism, with decreased DAT imaging using a new radiotracer. The patient showed clear corresponding laterality of clinical parkinsonism, MRI-based substantia nigra lesions, and DAT.
Case Report
A 67-year-old Japanese woman was admitted to our hospital after 4 days of a fever at 38.6 . Upon admission (Day 5), she showed a high fever (40.1 ), confusion, and delirium. Neurological examinations revealed impaired consciousness (Japan coma scale I-3 and Glasgow coma scale E4V4M5), saccadic eye tracking, hyperreflexia in all extremities, neck stiffness, and positive Kernig's sign. She also showed parkinsonian features, such as bradykinesia, a masked face, microphonia, bilateral resting tremor in the hands (right>left), and rigidity in all extremities (right>left). A laboratory blood test showed mild inflammatory reactions with an erythrocyte sedimentation rate (ESR) of 40/71 mm (1 and 2 hours), a white blood-cell (WBC) count of 13,800 μL, and 2.48 mg/dL of C-reactive protein (CRP). A cerebrospinal fluid (CSF) analysis showed pleocytosis (260/μL, mononuclear, 82% and polynuclear, 18%), elevated protein (137 mg/dL), and mildly reduced glucose (67 mg/dL; serum glucose 183 mg/dL). Brain magnetic resonance imaging (MRI) on day 9 revealed bilateral high-intensity lesions (left > right) in the medial temporal lobes, thalamus, and substantia nigra on a fluid-attenuated inversion recovery (FLAIR) image ( Figure A and B, arrowheads). Since herpes simplex or bacterial meningoencephalitis were initially suspected, we started acyclovir and antibiotics (ceftriaxone) combined with methylprednisolone pulse therapy. After these treatments, the high fever improved (Figure H) , but there was no change in the consciousness disturbance, and the parkinsonism worsened, especially the rigidity of the right upper and lower extremities ( Figure H ). An enzyme-linked immunosorbent assay (ELISA) detected Japanese encephalitis virus (JEV)-specific IgM in both the serum (7.22 index, cut off >2.0) and CSF (8.65 index) on day 5 of the illness. She was diagnosed with JE, which was confirmed by a hemagglutination inhibition test and a neutralization test during the convalescent phase (Table 1) .
Dopamine transporter (DAT) imaging using 123 I-labeled 
Discussion
Parkinsonism is one of the most common symptoms of JE patients, being present in as many as 45% of cases (1). Brain computed tomography (CT) and MRI studies often reveal lesions in the thalamus, basal ganglia, and midbrain (4). Srivastava et al. showed an affinity of JEV to the thalamus and midbrain after discovering a number of RNA copies of JEV in a rat model of JE (5).
Liao et al. showed the involvement of the nigrostriatal pathway in three JE patients presenting with parkinsonism in Taiwan by single-photon emission tomography (SPECT) using the radiotracer 99m Tc-TRODAT-1 for DAT imaging, and 123 I-iodobenzamide ( 123 I-IBZM) for D2 dopamine receptor imaging (Table 2) (2). All three patients showed bilateral substantia nigra lesions on brain MRI, albeit at different severities, but these did not reflect the corresponding clinical laterality. The decrease in DAT laterality did not simultaneously present as clinical laterality in cases 1 and 3 and was even reversed in case 2 ( Table 2 ). In contrast, 123 I-IBZM SPECT showed a decreased uptake in the striatum of cases 1 and 2, but an increased uptake in case 3. The laterality of the decrease in the D2 dopamine receptor corresponded to clinical laterality only in case 2, not in cases 1 or 3. However, in case 3, the increased uptake of 123 I-IBZM SPECT compensated for the laterality of its decreased DAT laterality. Another report from Taiwan also showed decreased DAT laterality in a JE patient using the same radiotracer, Tc-TRODAT-1, but the laterality of parkinsonism was not described (3) .
In the present case, DAT imaging with a different radiotracer, 
